Have you heard about chronic cough suppression?
New evidence supports a telehealth intervention as an extremely efficacious method
Among those with cough monitoring, the mean hourly cough rate dropped by 68%
Cough bouts decreased by 78%
https://t.co/E4BMuXEP82
Chung et al. reframed the question:
not “what is the cough today?” but “how often does today reflect the month?”
That shift - predictability over point estimates - makes continuous monitoring clinically consequential rather than merely descriptive.
If you are attending #CHEST#CHEST2025 - this study will be presented by PI - Laurie Slovarp - in the late breaking section on Thursday, October 21 in Chicago, Illinois titled "Digital Therapeutic For Refractory And Unexplained Chronic Cough: A Proof Of Concept Study"
@Novusnow How is that you posted that "update" at 8:19am when the outage was at least 2.5 hours old? And how is it that there's nothing on your webpage or "blog" that updates customers?
Quick math for reliable cough monitoring: intraclass correlation for mean cough rate jumps from 0.73 (1-day) to 0.91 (7-day). A week smooths noise and strengthens signal - ideal for baseline and endpoint assessment in trials.
An important milestone for Hyfe and for my team in particular. We're delighted to be working alongside KYORIN Pharmaceutical Co., Ltd. to build the first digital therapeutic app (DTx) for #chroniccough, bringing a much-needed treatment to those with cough in Japan.
We’re proud to announce our strategic partnership with KYORIN Pharmaceuticals to launch the world’s first prescription digital therapeutic (DTx) for chronic cough in Japan!
Read the full press release: https://t.co/iOz6BkPLq6
✨ Hyfe 2024 Wrapped ✨
This year was a breakthrough for cough science and monitoring technology. Hyfe advanced real-world monitoring, supported numerous clinical and research trials, and contributed to key conferences. 2025 is set to bring even greater innovation!
✨ CoughPro 2024 Wrapped ✨
As we wrap up the year, we’re proud of what we’ve achieved - thousands of coughs monitored, lives improved, and new features launched like cough management and better insights. Big things are coming in 2025 - stay tuned for more innovations! 🌟
In a recent review by Lilly et al. (2024), otolaryngologists #ENTs are encouraged to consider #speech therapy #SLT for patients with #ChronicCough early in treatment as an adjunct to medical management.
@OTOjournals@AAOHNS
⬇️
https://t.co/H2ZipQE1BB
New White Paper: Exploring Heart Rate and Cough Severity
By combining heart and respiratory data, we can better understand the impact of coughing on the body, especially for people with chronic conditions.
https://t.co/ezktppQSDs
@SensoryCloud and Hyfe announced promising results and progress in chronic cough treatment. Cough counts were measured continuously using Hyfe’s AI-powered technology.
Read more ⬇️
https://t.co/KpPlgNc2vg
🚨 New Whitepaper Alert! 🚨
In our latest whitepaper, we explored the issue of "other people's cough"
🔍 Curious? Dive into our novel approach and find out how this tech could reshape personalized healthcare and large-scale disease tracking: https://t.co/1Qgev0S5On
We're thrilled to have had 3 posters presented by Joe Brew and Mindaugas Galvosas, MD at the prestigious @EuroRespSoc#ERS2024 session on Artificial Intelligence and Machine Learning in Respiratory Care.
We were pleased to attend #ERS2024, where @joethebrew and @MGalvosas represented Hyfe.
#digitalhealth took center stage, with the 'cough report' highlighted by keynote speaker @Berci as an example of #AI integration in routine pulmonary healthcare.